Robert P. McMahon, PhD | Psychiatrist.com

Original Research

Clozapine Use in Patients with Benign Neutropenia

November 23, 2016

Is clozapine safe for patients with benign neutropenia? Many patients with lower than normal absolute neutrophil count do not qualify for clozapine therapy or are at risk of having...

Charles M. Richardson, Erica A. Davis, Gopal R. Vyas, et al

Letter to the Editor

Substance Use and Cannabis Withdrawal

September 1, 2016

Cannabis withdrawal symptoms are clinically significant because they may act as negative reinforcement for relapse to cannabis use. Here, the authors present data on psychoactive substance use before and...

Maju Mathew Koola, Deanna L. Kelly, Robert P. McMahon, et al

Original Research

Participants With Schizophrenia Retain the Information Necessary for Informed Consent During Clinical Trials

June 15, 2013

Bernard A. Fischer, Robert P. McMahon, Walter A. Meyer, et al

Original Research

Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis

April 5, 2011

Elaine Weiner, M. Patricia Ball, Alison S. Buchholz, et al

Original Research

Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study

January 12, 2010

Deanna L. Kelly, Robert P. McMahon, Fang Liu, et al

Original Research

A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia

April 7, 2009

Deanna L. Kelly, Robert W. Buchanan, Douglas L. Boggs, et al